MeSH term
Frequency | Condition_Probility | Adult | 21 | 0.0 |
Comparative Study | 17 | 0.0 |
Humans | 98 | 0.0 |
Binding Sites | 9 | 0.0 |
Enzyme Inhibitors/pharmacology | 6 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Protein Binding | 9 | 0.0 |
Research Support, Non-U.S. Gov't | 60 | 0.0 |
Amino Acid Sequence | 24 | 0.0 |
Child, Preschool | 2 | 0.0 |
Molecular Sequence Data | 26 | 0.0 |
Phosphorylation | 21 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 33 | 0.0 |
Spectrum Analysis, Mass | 4 | 0.0 |
Blotting, Western | 5 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
DNA/metabolism | 3 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Tyrosine/metabolism | 9 | 0.0 |
Vanadates/pharmacology | 2 | 1.0 |
Animals | 32 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Kinetics | 8 | 0.0 |
Ligands | 6 | 0.0 |
Mutagenesis, Site-Directed | 8 | 0.0 |
Mutation | 5 | 0.0 |
Point Mutation | 2 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Stereoisomerism | 2 | 0.0 |
Transfection | 9 | 0.0 |
Cell Line | 15 | 0.0 |
Gene Products, gag/*metabolism | 2 | 15.0 |
Mitogen-Activated Protein Kinase 3 | 5 | 0.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Mice | 9 | 0.0 |
Receptor, Epidermal Growth Factor/*metabolism | 3 | 0.0 |
Base Sequence | 7 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Hela Cells | 7 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Luminescent Proteins/genetics | 2 | 1.0 |
Phenotype | 2 | 0.0 |
Aged | 6 | 0.0 |
Genotype | 3 | 0.0 |
Male | 25 | 0.0 |
Middle Aged | 12 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
Circadian Rhythm | 2 | 0.0 |
Dietary Proteins/*administration & dosage | 2 | 7.0 |
Energy Metabolism/*physiology | 2 | 2.0 |
Amino Acids/blood | 3 | 6.0 |
Biological Markers | 2 | 0.0 |
Case-Control Studies | 5 | 0.0 |
Catecholamines/*metabolism | 2 | 3.0 |
Female | 26 | 0.0 |
Psychological Tests | 3 | 7.0 |
Child | 3 | 0.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Electrochemistry | 2 | 2.0 |
Energy Intake | 2 | 1.0 |
Osmolar Concentration | 2 | 0.0 |
Phenylalanine/blood | 5 | 17.0 |
Crystallography, X-Ray | 4 | 0.0 |
Models, Molecular | 7 | 0.0 |
Protein Conformation | 10 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Inositol Phosphates/metabolism | 2 | 1.0 |
Protein Structure, Secondary | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
*Models, Molecular | 2 | 1.0 |
Cell Adhesion | 4 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 3 | 0.0 |
CHO Cells | 4 | 0.0 |
Flavonoids/pharmacology | 2 | 0.0 |
Hamsters | 5 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Signal Transduction | 9 | 0.0 |
src-Family Kinases/*metabolism | 3 | 1.0 |
*Mutation | 4 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Subcellular Fractions/enzymology | 2 | 2.0 |
Hydroxylation | 2 | 0.0 |
Proteins/metabolism | 2 | 0.0 |
Tyrosine/*metabolism | 3 | 0.0 |
Tyrphostins/pharmacology | 2 | 1.0 |
DNA Mutational Analysis | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Amino Acids/*blood | 4 | 20.0 |
Insulin/pharmacology | 2 | 0.0 |
Regression Analysis | 3 | 0.0 |
Tyrosine/blood | 5 | 27.0 |
Proto-Oncogene Protein p21(ras)/*physiology | 2 | 11.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Tyrosine/*pharmacology | 2 | 40.0 |
Structure-Activity Relationship | 7 | 0.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Rats | 5 | 0.0 |
Substrate Specificity | 3 | 0.0 |
Models, Biological | 2 | 0.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Hydrogen Bonding | 3 | 1.0 |
Spectrum Analysis, Raman | 2 | 10.0 |
Neuropsychological Tests | 2 | 0.0 |
Phenylalanine/*blood | 2 | 9.0 |
Sex Factors | 2 | 0.0 |
Cell Adhesion Molecules/*chemistry | 2 | 12.0 |
Carbon Radioisotopes/diagnostic use | 2 | 3.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
Enzyme Activation | 5 | 0.0 |
*Mitogen-Activated Protein Kinases | 3 | 0.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1.0 |
Sequence Alignment | 2 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Tyrosine | 2 | 1.0 |
Adolescent | 3 | 0.0 |
Monophenol Monooxygenase/*genetics | 2 | 8.0 |
Conserved Sequence | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
ras Proteins/physiology | 2 | 6.0 |
Gene Library | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Antidepressive Agents/*therapeutic use | 2 | 13.0 |
Tryptophan/*blood | 4 | 44.0 |
Tyrosine/*blood | 5 | 12.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Psychiatric Status Rating Scales | 3 | 1.0 |
Peptide Fragments/metabolism | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
